Here's the live share price of OneSource Specialty Pharma along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of OneSource Specialty Pharma has gained 1.79% CAGR. Over the past year, the corresponding return has been 9.28%.
OneSource Specialty Pharma’s current P/E of -1,689.92x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| OneSource Specialty Pharma | 1.49 | 4.19 | 0.69 | 16.8 | 9.28 | 3 | 1.79 |
| Sun Pharmaceutical Industries | -0.57 | 3.28 | 3.73 | -7.6 | -9.08 | 18.48 | 29.21 |
| Divi's Laboratories | 2.65 | 18.41 | 6.34 | 10.85 | 14.59 | 23.31 | 17.28 |
| Cipla | -5.18 | -0.81 | 0.03 | -1.58 | -3.69 | 8.79 | 14.87 |
| Torrent Pharmaceuticals | -0.8 | -0.38 | -3.39 | 9.01 | 10.66 | 29.1 | 22.78 |
| Dr. Reddy's Laboratories | -6.61 | -3.78 | -1.68 | 1.37 | -4.72 | 10.6 | 4.3 |
| Mankind Pharma | -2.15 | -2.43 | -7.14 | -0.11 | -11.57 | 18.66 | 10.81 |
| Zydus Lifesciences | -3.15 | -1.79 | 2.64 | 10 | -2.99 | 30.95 | 18.88 |
| Lupin | 1.95 | -0.64 | 5.56 | -4.31 | -10.42 | 41.27 | 16.64 |
| Aurobindo Pharma | 4.93 | 4.74 | 5.46 | -6.06 | -18.73 | 28.36 | 8.42 |
| Alkem Laboratories | -0.73 | 0.83 | 12.48 | 8.53 | -5.2 | 20.39 | 15.68 |
| Abbott India | -3.15 | -2.92 | -13.89 | -5.7 | -1.05 | 14.62 | 13.33 |
| Glenmark Pharmaceuticals | 3.96 | -3.48 | -8.54 | 37.43 | 11.8 | 67.21 | 31.92 |
| Laurus Labs | 3.16 | 9.45 | 12.55 | 53.86 | 91.09 | 28.05 | 25.98 |
| Biocon | 3.58 | 7.36 | -2.86 | 16.74 | 17.02 | 11.37 | -1.64 |
| GlaxoSmithKline Pharmaceuticals | -4.58 | -2.61 | -10.55 | -8 | -3.86 | 23.97 | 13.24 |
| Anthem Biosciences | -1.31 | -7.94 | -3.73 | -2.73 | -2.73 | -0.92 | -0.55 |
| Ipca Laboratories | 0.17 | -4.35 | -12.53 | -7.87 | -21.04 | 11.98 | 2 |
| Gland Pharma | -0.6 | -2.66 | -2.59 | 37.25 | 17.21 | 2.61 | 1.15 |
| Ajanta Pharma | 2.22 | 2.85 | -8.44 | -4.54 | -19.88 | 23.86 | 18.63 |
Over the last one year, OneSource Specialty Pharma has gained 9.28% compared to peers like Sun Pharmaceutical Industries (-9.08%), Divi's Laboratories (14.59%), Cipla (-3.69%). From a 5 year perspective, OneSource Specialty Pharma has underperformed peers relative to Sun Pharmaceutical Industries (29.21%) and Divi's Laboratories (17.28%).
| Day | SMA | EMA |
|---|---|---|
| 5 | 1,830.01 | 1,839.94 |
| 10 | 1,837 | 1,839.06 |
| 20 | 1,838.31 | 1,838.81 |
| 50 | 1,841.45 | 1,849.19 |
| 100 | 1,918.49 | 1,828.2 |
| 200 | 1,648.4 | 0 |
In the latest quarter, OneSource Specialty Pharma saw a drop in promoter holding to 29.78%, while DII stake increased to 18.48%, FII holding rose to 19.39%, and public shareholding moved down to 32.34% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 10,66,196 | 0.76 | 196.22 | |
| 7,97,281 | 3.35 | 146.73 | |
| 6,49,672 | 0.92 | 119.57 | |
| 4,85,952 | 0.38 | 89.43 | |
| 4,40,404 | 1.34 | 81.05 | |
| 4,29,059 | 1.32 | 78.96 | |
| 4,11,531 | 2.74 | 75.74 | |
| 3,80,829 | 0.24 | 70.09 | |
| 3,18,723 | 4 | 58.66 | |
| 2,94,408 | 0.59 | 54.18 |
* Excluding Index & Arbitrage Funds
Date Time | Announcement |
|---|---|
| Sep 27, 2025, 4:50 AM IST | OneSource Specialty - Investor Presentation |
| Sep 27, 2025, 4:26 AM IST | OneSource Specialty - Announcement under Regulation 30 (LODR)-Scheme of Arrangement |
| Sep 24, 2025, 10:02 PM IST | OneSource Specialty - Voting Results Of The Annual General Meeting Held On 22Nd September, 2025 |
| Sep 23, 2025, 3:57 AM IST | OneSource Specialty - Shareholder Meeting / Postal Ballot-Outcome of AGM |
| Sep 23, 2025, 12:59 AM IST | OneSource Specialty - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
OneSource Specialty Pharma Ltd. is a Public Limited Listed company incorporated on 12/06/2007 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is U74140MH2007PLC432497 and registration number is 432497. Currently Company is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company's Total Operating Revenue is Rs. 1299.59 Cr. and Equity Capital is Rs. 11.44 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for OneSource Specialty Pharma is ₹1,860.60 as on Oct 31, 2025.
The OneSource Specialty Pharma is operating in the Pharmaceuticals and health care Sector. It is classified as a Midcap stock on the BSE.
The market cap of OneSource Specialty Pharma is ₹21,308.56 Cr as on Oct 31, 2025.
Today’s highest and lowest price of OneSource Specialty Pharma are ₹1,864.40 and ₹1,832.30.
The 52-week high/low is the highest and lowest price at which OneSource Specialty Pharma stock has traded in the past 52-week or nearly a year. The 52-week high of OneSource Specialty Pharma is ₹2,249.65 and 52-week low of OneSource Specialty Pharma is ₹1,163.05 as on Oct 31, 2025.
The OneSource Specialty Pharma has shown returns of 0.54% over the past day, 4.19% for the past month, -5.52% over 3 months, 9.28% over 1 year, 3.0% across 3 years, and 1.79% over 5 years.
P/E ratio of and PB ratio of OneSource Specialty Pharma are -1,689.92 and 3.62 on Oct 31, 2025. While the company gives a dividend yield of 0.00 per annum.